Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap Vaccination Timing for Preeclampsia Prevention
NCT04424693Phase 4Unknown
- Sponsor
- Institute of Arthritis Research
- Start
- Dec 2020
- Primary completion
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of tdap vaccine in preeclampsia, sponsored by Institute of Arthritis Research. Status: unknown.
02
Drugs
tdap vaccine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04424693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04424693.